Previous 10 | Next 10 |
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2020 Q4 earnings call. For further details see: IQVIA Holdings Inc. 2020 Q4 - Results - Earnings Call Presentation
IQVIA (IQV) Q4 results:Revenue: $3.3B (+13.8%), beats by $160M.Net income: $119M, compared with $16M in the prior year quarter; non-GAAP net income: $411M (+20%); EPS: $0.61; non-GAAP EPS: $2.11; non-GAAP EBITDA: $735M (+14.5%).Q4 Free Cash Flow of $574MQ1 guidance:...
IQVIA (IQV): Q4 Non-GAAP EPS of $2.11 beats by $0.10; GAAP EPS of $0.61 misses by $0.24.Revenue of $3.3B (+13.8% Y/Y) beats by $160M.Shares +4.4% PM.Press Release For further details see: IQVIA EPS beats by $0.10, beats on revenue, raises FY21 guidance
Revenue of $3,298 million for the fourth quarter grew 13.9 percent year-over-year Adjusted EBITDA of $735 million for the fourth quarter increased 14.5 percent year-over-year GAAP Diluted Earnings per Share of $0.61 for the fourth quarter; Adjusted Diluted Earnings p...
IQVIA (NYSE:IQV) is scheduled to announce Q4 earnings results on Wednesday, February 10th, before market open.The consensus EPS Estimate is $2.01 (+15.5% Y/Y) and the consensus Revenue Estimate is $3.14B (+8.3% Y/Y).Over the last 2 years, IQV has beaten EPS estimates 100% of the time and has ...
IQVIA™ (NYSE: IQV) today announced that it has been recognized as a top performer by survey respondents in Industry Standard Research’s eCOA/ePRO Market Dynamics and Service Provider Performance (4th Edition) report for overall performance, capabilities, cost, system f...
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA has received this distinction every year, following the merger between IMS Health and Quintiles in 2016. IQVIA is recogni...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its fourth-quarter and full-year 2020 financial results before the market opens on Wednesday, February 10, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that...
IQVIA demonstrates a strong sequential growth pattern, in near recovery to pre-pandemic volumes. Management have reinstated the buyback program, with ~$1 billion in authorization, and look set on acquisition targeting across FY2021. We feel shares are worth ~$197 at this point, an...
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Laboratoires Théa, the leading independent eye care group in Europe, has selected IQVIA Technologie...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...